Kenvue Inc. (KVUE) Annual Revenue
The annual revenue for Kenvue Inc. (KVUE) is $15.12B with a period-over-period change of (2.14%). Annual revenue is the total sales generated during the company's fiscal year.
KVUE Annual Revenue Chart
Annual fiscal-year revenue; no daily interpolation.
Annual Revenue History
| Date | Annual Revenue | % Change |
|---|---|---|
| 2025 | $15.12B | (2.14%) |
| 2024 | $15.46B | +0.07% |
| 2023 | $15.44B | +3.30% |
| 2022 | $14.95B | (0.69%) |
| 2021 | $15.05B | +4.06% |
| 2020 | $14.47B | +1.00% |
| 2019 | $14.32B | - |
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry